Therapy of moderate-to-severe Graves’ orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density
Sign Up to like & getrecommendations! Published in 2018 at "Endocrine"
DOI: 10.1007/s12020-018-1823-x
Abstract: PurposeTo evaluate the influence of intravenous methylprednisolone (IVMP) pulse administration on bone mineral density (BMD) of the lumbar spine and the femoral neck in patients with moderate-to-severe Graves’ orbitopathy (GO).MethodsThirty-five patients with GO in euthyreosis… read more here.
Keywords: spine femoral; femoral neck; bmd; intravenous methylprednisolone ... See more keywords
Rescue immunoadsorption treatment for neuromyelitis optica spectrum disorder attacks unresponsive to intravenous methylprednisolone
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Neuroimmunology"
DOI: 10.1016/j.jneuroim.2021.577604
Abstract: We aimed to evaluate the value of immunoadsorption (IA) treatment after the failure of intravenous methylprednisolone (IVMP) therapy for neuromyelitis optica spectrum disorder (NMOSD). Sixty-one NMOSD attacks unresponsive to IVMP were included: 22 patients received… read more here.
Keywords: treatment; intravenous methylprednisolone; immunoadsorption treatment; neuromyelitis optica ... See more keywords
Efficacy and tolerability of intravenous immunoglobulin versus intravenous methylprednisolone treatment in anti‐N‐methyl‐d‐aspartate receptor encephalitis
Sign Up to like & getrecommendations! Published in 2021 at "European Journal of Neurology"
DOI: 10.1111/ene.15214
Abstract: The aim was to compare the effectiveness and safety of intravenous immunoglobulin (IVIg) or intravenous methylprednisolone (IVMP) versus IVIg plus IVMP (IPI) as initial therapy in anti‐N‐methyl‐d‐aspartate receptor (NMDAR) encephalitis. read more here.
Keywords: intravenous immunoglobulin; methyl aspartate; aspartate receptor; intravenous methylprednisolone ... See more keywords
ABCB1 gene polymorphisms impact the effect of high‐dose intravenous methylprednisolone therapy on optic neuritis associated with AQP4‐IgG‐positive neuromyelitis optica spectrum disorder
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Pharmacy and Therapeutics"
DOI: 10.1111/jcpt.13675
Abstract: Patients with optic neuritis (ON) have significant individual differences in their response to high‐dose intravenous methylprednisolone (HIMP) therapy. This study aims to evaluate the association between gene polymorphisms and the efficacy of HIMP therapy in… read more here.
Keywords: therapy; gene polymorphisms; optic neuritis; dose intravenous ... See more keywords
Comparison of two different regimens of intravenous methylprednisolone for patients with moderate to severe and active Graves' ophthalmopathy: a prospective, randomized controlled trial.
Sign Up to like & getrecommendations! Published in 2017 at "Endocrine journal"
DOI: 10.1507/endocrj.ej16-0083
Abstract: The intravenous methylprednisolone (iv MP) strategy for Graves' ophthalmopathy (GO) and evaluation of its activity against the disease warrants further exploration. A prospective randomized controlled trial for 3 months was performed in a tertiary referral… read more here.
Keywords: randomized controlled; prospective randomized; graves ophthalmopathy; controlled trial ... See more keywords
A real-world cost-effectiveness analysis of nebulized budesonide and intravenous methylprednisolone in acute exacerbation of chronic obstructive pulmonary disease
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.892526
Abstract: Objective: To assess the cost-effectiveness of nebulized budesonide and intravenous methylprednisolone in the treatment of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) in a real-world setting. Materials and methods: Data from 291 patients with… read more here.
Keywords: methylprednisolone; cost; intravenous methylprednisolone; nebulized budesonide ... See more keywords